Health and Me

Itisha Arya

Wegovy and Zepbound Weight Loss Drug Prices May Soon Fall In The US: Here’s What You Should Know

wegovy price decrease

<span>Wegovy</span>: Eli Lilly and <span>Novo Nordisk</span> are reportedly preparing to finalize agreements with the <span>Trump</span> administration that could significantly reduce the cost of their blockbuster weight loss medications in return for <span>Medicare</span> coverage, according to a <span>White House</span> source quoted by Reuters on Tuesday.

Patients in the United States pay some of the highest prices in the world for prescription drugs—often nearly triple what consumers in other developed nations spend. President <span>Donald Trump</span> has been urging major pharmaceutical companies to bring prices down to align more closely with global standards.

<h2><span rel="noindex">Trumprx</span>: Cost of Weight Loss Drugs Is Finally Dropping</h2>

Two of the most sought-after medications, Wegovy and Zepbound, currently cost more than $1,000 a month at list price. The high cost has made them unaffordable for many Americans, especially those without insurance or whose plans do not cover the drugs. A survey by the health policy group KFF in May 2024 found that about half of adults taking these medications find it difficult to manage the expense.

However, that may soon change. The Trump administration is expected to unveil a new deal with Eli Lilly and Novo Nordisk that would cut the monthly price of certain weight loss drugs to under $150. The official announcement is set for November 6, marking a major step toward making these treatments more accessible.

<h2>What Price Cap Did Trump Negotiate for Weight Loss Drugs?</h2>

According to reports from Endpoints News and The Wall Street Journal, the agreement would set the lowest dose of Lilly’s and Novo’s weight loss drugs at $149 per month. In exchange, the companies would gain Medicare coverage for their products—a milestone for obesity treatments, which are not currently included under Medicare.

Both Lilly’s Zepbound and Novo’s Wegovy have been immensely popular but remain out of reach for many due to high prices and inconsistent insurance coverage.

<h2>TrumpRx to Offer Discounted Weight Loss Drugs?</h2>

Separately, The Wall Street Journal also noted that the administration is working on an additional deal with both drugmakers to sell select obesity medications directly through the upcoming TrumpRx platform, a government-run consumer site expected to launch in 2026. This would follow previous arrangements where other discounted drugs were offered through federal programs.

President Trump has consistently pushed for most favored nation pricing, a policy aimed at ensuring Americans pay no more than citizens of other advanced economies. On September 30, he announced such a deal with Pfizer, reducing Medicaid drug costs.

In another move, he recently confirmed that EMD Serono, the country’s largest fertility drug maker, had agreed to lower the price of a common IVF medication, continuing his administration’s push to reduce the cost of essential treatments.

Although many insurance plans cover GLP-1 drugs when prescribed for diabetes or heart disease, more than half of employer-based plans still do not extend coverage to obesity-related prescriptions.

In 2024, about 44% of large employers offered coverage for GLP-1 drugs used for weight loss, compared to 41% in 2023, according to data from Mercer, a benefits consulting firm.

This potential price cut could therefore play a crucial role in bridging that gap—making effective weight loss medications accessible to a wider group of Americans.

Health Conditions A-Z

health

wegovy-price-decrease

wegovy

did wegovy price drop

trumprx

trump

novo nordisk

medicare

donald trump

white house

novos wegovy

us-fda-asks-lilly-to-share-more-health-safety-data-on-weight-loss-pill-foundayo

US FDA Asks Lilly To Share More Health Safety Data On Weight Loss Pill Foundayo

india-introduces-healthy-lifestyle-mental-wellness-as-priority-areas-at-brics-meet

India Introduces Healthy Lifestyle, Mental Wellness as Priority Areas at BRICS Meet

hernia-surgery

Have Hernia Surgeries Become Less Painful?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Wegovy: Eli Lilly and Novo Nordisk are reportedly preparing to finalize agreements with the Trump administration that could significantly reduce the cost of their blockbuster weight loss medications in return for Medicare coverage, according to a White House source quoted by Reuters on Tuesday.Patients in the United States pay some of the highest prices in the world for prescription drugs—often nearly triple what consumers in other developed nations spend. President Donald Trump has been urging major pharmaceutical companies to bring prices down to align more closely with global standards.Trumprx: Cost of Weight Loss Drugs Is Finally DroppingTwo of the most sought-after medications, Wegovy and Zepbound, currently cost more than $1,000 a month at list price. The high cost has made them unaffordable for many Americans, especially those without insurance or whose plans do not cover the drugs. A survey by the health policy group KFF in May 2024 found that about half of adults taking these medications find it difficult to manage the expense.However, that may soon change. The Trump administration is expected to unveil a new deal with Eli Lilly and Novo Nordisk that would cut the monthly price of certain weight loss drugs to under $150. The official announcement is set for November 6, marking a major step toward making these treatments more accessible.What Price Cap Did Trump Negotiate for Weight Loss Drugs?According to reports from Endpoints News and The Wall Street Journal, the agreement would set the lowest dose of Lilly’s and Novo’s weight loss drugs at $149 per month. In exchange, the companies would gain Medicare coverage for their products—a milestone for obesity treatments, which are not currently included under Medicare.Both Lilly’s Zepbound and Novo’s Wegovy have been immensely popular but remain out of reach for many due to high prices and inconsistent insurance coverage.TrumpRx to Offer Discounted Weight Loss Drugs?Separately, The Wall Street Journal also noted that the administration is working on an additional deal with both drugmakers to sell select obesity medications directly through the upcoming TrumpRx platform, a government-run consumer site expected to launch in 2026. This would follow previous arrangements where other discounted drugs were offered through federal programs.President Trump has consistently pushed for most favored nation pricing, a policy aimed at ensuring Americans pay no more than citizens of other advanced economies. On September 30, he announced such a deal with Pfizer, reducing Medicaid drug costs.In another move, he recently confirmed that EMD Serono, the country’s largest fertility drug maker, had agreed to lower the price of a common IVF medication, continuing his administration’s push to reduce the cost of essential treatments.Insurance Coverage Still UnevenAlthough many insurance plans cover GLP-1 drugs when prescribed for diabetes or heart disease, more than half of employer-based plans still do not extend coverage to obesity-related prescriptions.In 2024, about 44% of large employers offered coverage for GLP-1 drugs used for weight loss, compared to 41% in 2023, according to data from Mercer, a benefits consulting firm.This potential price cut could therefore play a crucial role in bridging that gap—making effective weight loss medications accessible to a wider group of Americans.